• SENSEX 74,529.08
    -329.91 (--0.44%)
  • BANKNIFTY 56,215.55
    -255.10 (--0.45%)
  • Pine Labs
    205.00 283.70(%)
  • HDFC Bank
    738.70 682.00(%)
  • Meesho
    244.80 254.65(%)
  • Glass Wall Syst.
    318.00 318.00(%)
  • Cholaman.Inv.&Fn
    1,756.50 1,299.80(%)
  • Solar Industries
    20,243.65 22,630.05(%)
  • Cupid
    265.35 298.95(%)
  • Aster DM Quality
    746.55 519.80(%)
  • Protean eGov
    656.45 940.00(%)
  • Gabriel India
    1,495.35 1,600.00(%)
  • Nippon ETF Liq.
    999.99 978.01(%)
  • Transrail Light
    487.90 800.35(%)
  • Reliance Industries
    1,237.80 1,232.35(%)
  • JSW Dulux
    3,131.20 2,649.05(%)
  • Kaynes Tech
    3,427.35 2,995.85(%)
  • Apar Inds.
    17,916.55 6,800.00(%)
  • Titan Company
    4,983.70 5,187.45(%)
  • Dixon Technolog.
    12,997.00 9,605.05(%)
  • Eternal
    341.80 368.40(%)
  • Larsen & Toubro
    3,867.50 3,288.65(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Medico Remedies Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 71781.0
  • ISIN : INE630Y01024
33.96 0 (-0.29%)
  • As on 22 Sep 2026 (EOD)

  • Today’s Low

    33.75

  • Today’s High

    34.65

  • Open

    34.50

  • Perv Close

    34.06

  • 52W Low

    30.22

  • 52W High

    56.88

Key Indicators

  • P/E(TTM)

    20.40

  • Mar.Cap (₹Cr.)

    281.81

  • Div & Yield %

    0.00

  • Book Value(₹)

    9.10

  • Debt-Equity Ratio

    -0.29

  • AGM Date

    22-Sep-2026

  • EPS

    1.66

  • P/E Ratio

    20.40

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    281.81

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    16.60

  • BV (₹)

    9.10

  • Sales( ₹ in Cr.)

    206.38

  • NP (in Cr.)

    13.10

  • NP Var(%)

    30.0

  • Div%

    0.0

  • CPS (₹)

    2.00

  • EPS (₹)

    1.60

  • Traded Value (₹ in Lakhs)

    280.98

  • 52 Week High

    56.88

  • 52 Week Low

    30.22

  • Price BSE

    34.0

  • Price NSE

    34.00

  • Market Capital( in Cr.)

    280.98

  • P/C Ratio

    17.40

  • P/E Ratio

    21.50

  • Price Vs.BV

    1.60

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 206.38 150.94 144.92 140.44 121.02 122.39
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 206.38 150.94 144.92 140.44 121.02 122.39
Other Income 5.93 2.69 2.13 3.95 2.03 1.03
Stock Adjustments 1.67 5.16 -2.04 1.18 0.26 -1.54
Total Income 213.98 158.79 145.01 145.57 123.31 121.88
EXPENDITURE :            
Raw Materials 153.00 113.49 107.87 106.05 87.55 90.69
Power and Fuel Cost 3.67 2.92 2.55 2.47 2.29 1.91
Employee Cost 5.71 4.70 5.92 5.68 5.41 4.50
Other Manufacturing Expenses 11.02 7.72 6.25 5.48 6.44 5.25
Selling and Administration Expenses 16.58 12.41 6.49 11.92 11.20 10.60
Miscellaneous Expenses 1.04 -0.15 0.89 0.40 1.05 2.66
Employee Benefit Expenses 5.71 4.70 5.92 5.68 5.41 4.50
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 191.02 141.10 129.97 132.00 113.95 115.61
Operating Profit 22.96 17.69 15.03 13.57 9.36 6.27
Interest 1.81 1.16 0.82 0.75 0.66 0.92
Gross Profit 21.15 16.53 14.21 12.82 8.70 5.35
Depreciation 3.09 3.03 2.88 2.72 2.22 1.65
Profit Before Tax 18.06 13.50 11.33 10.10 6.48 3.70
Current Tax 4.89 3.42 3.17 2.50 1.79 1.06
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.06 -0.01 -0.12 0.36 -0.12 0.05
Reported Net Profit 13.12 10.09 8.29 7.24 4.81 2.59
Extraordinary Items 0.01 0.00 0.00 0.00 -0.03 0.00
Adjusted Net Profit 13.11 10.09 8.29 7.24 4.84 2.59
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 42.30 32.21 23.92 16.67 11.86 9.91
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down 55.42 42.30 32.21 23.92 16.67 12.50
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 1.58 1.22 1.00 0.87 2.90 6.24
Earnings Per Share(Adj)-Unit Curr 1.58 1.22 1.00 0.87 0.58 0.31
Book Value 9.10 7.53 6.31 5.28 22.04 78.22
Book Value(Adj)-Unit Curr 9.10 7.53 6.31 5.28 4.41 3.91

Shareholding Pattern

  • Promoter Group

    61.38%

  • Public Share Holding

    38.62%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 50,937,145 61.38 50,937,145 6
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 50,937,145 61.38 50,937,145 6
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 64,722 0.08 64,722 2
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 64,722 0.08 64,722 2
2] Non Institution
Bodies Corporate 3,918,787 4.72 3,918,387 69
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 477,853 0.58 477,853 117
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 1,574,586 1.90 1,573,786 206
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 7,066,960 8.52 7,066,960 29
Individuals holding nominal share capital up to Rs. 1 lakh 12,579,636 15.16 12,578,036 15,430
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 5,664,309 6.83 5,664,309 1
Others 0 0.00 0 0
Sub Total 31,982,133 38.54 31,979,333 15,855
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 82,984,000 100.00 82,981,200 15,863

Company Background

Medico Remedies LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Medico Remedies Ltd
  • BSE Code : 71781.0
  • ISIN : INE630Y01024

  • Incorporation Year

    1994

  • Registered Office

    1105/1106 11-Flr Hubtown Solar
    N S Phadke Marg Andheri East, Mumbai,
    Maharashtra-400069

  • Telephone

    91-22-2670 1055/66

  • FAX

  • Chairman

    Haresh Mehta

  • Managing Director

  • Company Secretary

    Vidhi Ankit Shah

  • Auditor

    V J Shah & Co/Shah Shroff & Associates

  • Face Value

    2

  • Listing

    NSE

  • Registrar

    Cameo Corporate Services Ltd
    Subramanian Building,
    1ST Floor No 1,Club House Road
    Mumbai - Chennai - 600002

Medico Remedies Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Medico Remedies 33.86 212.31 206.38 20.40 23.23
Abbott India 27,223.20 7,217.19 6,929.05 35.83 43.78
Astrazeneca Phar 6,712.15 2,304.07 2,275.58 98.93 27.86
Glaxosmi. Pharma 2,871.50 3,932.76 3,790.20 45.87 58.17
Novartis India 1,976.65 393.10 354.33 49.92 15.94
Cipla 1,381.00 20,102.60 18,979.95 36.29 13.88
Bliss GVS Pharma 690.40 773.53 729.81 64.16 12.51
Amrutanjan Healt 500.25 520.13 502.55 26.79 24.16
Fermenta Biotec. 471.40 474.15 450.25 22.01 18.77
Guj. Themis Bio. 411.75 168.25 165.82 110.09 18.05
Ambalal Sarabhai 38.82 19.52 3.94 71.89 6.77